Key result
Blood pressure control, statins, and protein restriction help slow chronic renal failure progression.
Answers are grounded in this paper and cite their sources.
Chronic renal failure is characterized by a persistently abnormal glomerular filtration rate. The rate of progression varies substantially. Several morphologic features are prominent: fibrosis, loss of native renal cells, and infiltration by monocytes and/or macrophages. Mediators of the process include abnormal glomerular hemodynamics, hypoxia, proteinuria, hypertension, and several vasoactive substances (ie, cytokines and growth factors). Several predisposing host factors may also contribute to the process. Treatments to delay progression are aimed at treating the primary disease and at strictly controlling the systemic blood pressure and proteinuria. The role of antihypertensive agents, statins, and use of other maneuvers such as protein restriction and novel approaches are also discussed herein.
No takes yet. Share an insight, caveat, or question.
Henry T. Yu (2003) conducted a review in Chronic renal failure. Antihypertensive agents, statins, protein restriction, and blood pressure/proteinuria control was evaluated on Progression of chronic renal failure. Antihypertensive agents, statins, protein restriction, and strict blood pressure and proteinuria control are discussed as strategies to delay chronic renal failure progression.
Synapse has enriched 10 related papers. Consider them for comparative context: